Not possible to specify

441 trials 102 recruiting

Filter these 441 trials by phase, country and sponsor.

Open in Search →

Bioequivalence of Lisdexamfetamine dimesylate 10 mg/mL Oral Solution in Healthy Participants Under Fasting Conditions. Ended

2024-516828-33-00 No medical condition. 2 2024-11-15
A study in healthy people to test how 2 different formulations of BI 690517 are taken up in the body and how probenecid influences the amoun… Ended

2024-513590-45-00 Healthy volunteer trial 3 2024-11-12
A Single Dose, Non-randomised, Open-label, Parallel Group Study to Assess the Pharmacokinetics, Safety, and Tolerability of AZD4144 in Parti… Ended

2024-513848-28-00 Healthy Volunteers 3 2024-11-11
Single-Ascending Doses of 2-Methoxyestradiol in Healthy Non-Pregnant Female Subjects. Ended

2024-516854-23-00 No medical condition. 1 2024-11-11
A study to assess the effect of gemfibrozil, itraconazole and phenytoin on levels of IPN60250 in the blood of healthy adult participant. Ended

2024-513891-16-00 Not applicable 3 2024-11-08
A study in healthy men to test whether BI 1815368 influences the amount of metformin in the body Ended

2024-515911-23-00 Healthy volunteer trial 3 2024-11-06
Bioequivalence clinical trial of two formulations of loperamide. Ended

2024-515531-29-00 Healthy volunteers 2 2024-11-04
A study in healthy people to test how 2 different doses of BI 1291583 are taken up in the body when given in 3 different formulations. Ended

2023-510260-13-00 Healthy volunteer trial 3 2024-10-21
A study investigating the safety, absorption, and elimination of radioactively labeled RO7269162, a new compound that may potentially be use… Ended

2024-513234-37-00 Healthy males volunteers 3 2024-10-16
Study of total post-thyroidectomy hypocalcemia after preoperative cholecalciferol supplementation Ended

2024-516793-30-00 Thyroidectomy is a common operation. Transient postoper 5 2024-10-16
Prospective double-blind randomized comparative study of the use of methoxyflurane vs placebo in the management of pain in oral and dental e… Ended

2023-508216-29-00 Dental care 5 2024-10-14
A study in healthy people to compare 2 different formulations of nerandomilast tablets when taken with or without food Ended

2024-511245-18-00 Healthy volunteer trial 3 2024-10-11
Study with healthy volunteers to investigate the safety, tolerability, blood concentration and some effects of various amounts of the pharma… Ended

2023-507753-15-00 Healthy Volunteers 3 2024-10-08
Bioequivalence of Ruxolitinib 20 mg Tablets in Healthy Participants Under Fasting Conditions. Ended

2024-515947-49-00 No medical condition. 2 2024-10-07
Randomized, crossover, two-period, comparative bioavailability study of two ibuprofen (arginate) formulations, administered as solutions in … Ended

2024-514478-37-00 Healthy volunteers 3 2024-10-04
Bioequivalence of Linagliptin 5 mg Film-Coated Tablets in Healthy Participants Under Fasting Conditions Ended

2024-516400-42-00 No medical condition. 2 2024-10-02
Pharmacokinetics and the Effect of Food on the Pharmacokinetics of TW102 in Healthy Subjects. Ended

2024-510936-31-00 No medical condition. 3 2024-10-01
An open-label, crossover trial in otherwise healthy volunteers with allergic rhinitis to evaluate the relative bioavailability and hemodynam… Ended

2024-514037-38-00 Anaphylaxis 3 2024-10-01
A randomized, investigator masked pilot study to establish the experimental conditions and select the criteria to compare topical applicatio… Ended

2023-504881-42-01 None - Healthy subjects 3 2024-09-25
A study in healthy men to test how BI 1839100 is taken up and handled by the body Ended

2024-510870-26-00 Healthy volunteer trial 3 2024-09-24
Comparative Bioavailability of Cabozantinib Film-Coated Tablets in Healthy Participants Under Fasting Conditions Ended

2024-511647-25-00 No medical condition. 2 2024-09-24
Bioequivalence clinical trial of two formulations of bilastine. Ended

2024-515077-96-00 Healthy volunteers 2 2024-09-13
Bioequivalence of Lenvatinib 10 mg Capsules versus Lenvima® 10 mg Capsules in Healthy Participants Under Fasting Conditions. Ended

2024-512908-19-00 No medical condition. 2 2024-09-09
Evaluation of bioequivalence of two products containing 400 mg ibuprofen and 100 mg caffeine: Ibuprofen / Caffeine 400 mg / 100 mg coated gr… Ended

2023-509752-34-00 No therapeutic indication in the current trial with hea 2 2024-09-07